Group 1171274671


5 Key Benefits of Participating in a Paid Clinical Trials

Are you trying to decide whether to participate in a paid clinical trial? Even if you are hesitant to be part of a trial, you may be ...
Read More

How You Can Stop the Spread of COVID in the Future

Did you know that there are four main strains of the flu called A, B, C, and D? COVID-19 is no different, and we are seeing new ...
Read More

How to Participate in Clinical Trials

Approximately half a million Americans signed up to participate in COVID-19 vaccine clinical trials. Researchers are still in need of more than 1 million more people to ...
Read More

How COVID Clinical Trials Are Building Towards a Better Future

Do you remember when you were first sent home due to a novel coronavirus? People were throwing around estimates for how long we have to ...
Read More

Are Clinical Trials Covered by Insurance?

In 2021 alone, the FDA approved 50 new drugs. Before getting approval, drugs must go through clinical trials. Clinical trials allow doctors to test new drugs ...
Read More

Questions You Should Ask When Participating in a Clinical Trial

If you’re thinking about participating in a clinical trial, there are a few things you may wish to consider. Clinical trials are a great way ...
Read More

In The Community

1 (1)

Cullman clinic offers COVID antibody treatment

There is promising news in the fight against COVID-19 in Cullman, an area hit hard during the pandemic.


Monoclonal antibodies ‘the answer’ to Alabama’s COVID surge, doctors say

We witnessed first hand the effectiveness of the Monoclonal Antibody Therapy in subduing the COVID-19 virus. Simply put, these are antibodies made in a lab to help stimulate your body’s defense to the Virus. Very safe and effective treatment.


Orasure Technologies Receives Three Emergency Use Authorizations for Its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

Cullman Clinical Trials staff and volunteers helped make possible!


SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

Being part of cutting-edge and relevant research is not always an easy path but a quite meaningful one. Our heartfelt gratitude goes out to our patients and staff for their participation and hard work!

Screen Shot 2022-03-30 at 2.44.52 PM

Clinical trial for COVID-19 treatment begins in Cullman, participants needed

One of the latest clinical trials is happening in Cullman.


GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19

The Monoclonal Antibody made by VIR that we were working on just got Emergency Use Authorization by the FDA.

Become A Paid Participant